Associations and prognostic significance of p27Kip1, Jab1 and Skp2 in non‑Hodgkin lymphoma

Ma,Yan; Yan,Meijuan; Huang,Hua; Zhang,Li; Wang,Qian; Zhao,Yaqi; Zhao,Jianmei

doi:10.3892/mco.2016.986

Associations and prognostic significance of p27Kip1, Jab1 and Skp2 in non‑Hodgkin lymphoma

Authors:
- Yan Ma
- Meijuan Yan
- Hua Huang
- Li Zhang
- Qian Wang
- Yaqi Zhao
- Jianmei Zhao
View Affiliations

Affiliations: Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China, Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, P.R. China
Published online on: August 10, 2016 https://doi.org/10.3892/mco.2016.986
Pages: 357-364
Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non-Hodgkin lymphoma (NHL) is a primary tumor arising in lymph nodes and lymphoid tissue. The incidence of NHL is increasing at an annual rate of 3%. The human Jun activation domain‑binding protein 1/COP9 signalosome subunit 5 (Jab1/CSN5) is a negative regulator of the cell cycle inhibitor p27Kip1 and abnormal expression of Jab1 is correlated with reduced p27 expression and associated with advanced tumor stage and poor prognosis in several human cancers. F‑box protein S‑phase kinase‑interacting protein‑2 (Skp2), the substrate recognition subunit of the Skp1‑Cul1‑F‑box protein ubiquitin protein ligase complex, is required for the ubiquitination and consequent degradation of p27. The Skp2 protein is overexpressed in several human cancers and is associated with the degree of differentiation and the prognosis. The aim of the present study was to investigate the expression status of p27Kip1, Jab1 and Skp2 by immunohistochemistry, and assess their prognostic significance in patients with NHL. Immunohistochemical analysis revealed an inverse association between Jab1 and p27 in NHL tissue samples. Kaplan‑Meier analysis demonstrated that Jab1 overexpression, Skp2 overexpression and low p27 expression were significantly associated with poor prognosis. Among clinicopathological parameters, overexpression of Jab1 was significantly associated with tumor size and International Prognostic Index (IPI), whereas Skp2 expression was significantly associated with metastasis and IPI. These findings suggest that the overexpression of Jab1 or Skp2 plays an important role in the pathogenesis of NHL. Thus, the expression of p27Kip1, Jab1 and Skp2 provided a clinical reference for the treatment of NHL.

View Figures

View References

1	Wu M and Zhu J: Changes in nutrition metabolism of lymphoma after treatment and the nutritional supports. Acta Academiae Medicinae Sinicae. 36:446–449. 2014.(In Chinese). PubMed/NCBI
2	Fu ZY, Zhu J, Song YQ, Liu WP, Ji XQ and Zhan SY: Prognostic analysis of 525 Chinese patients with diffuse large B-cell lymphoma. J Peking Univ (Health Sci). 46:405–411. 2014.(In Chinese).
3	Zhao H, Bauzon F, Bi E, Yu JJ, Fu H, Lu Z, Cui J, Jeon H, Zang X, Ye BH and Zhu L: Substituting threonine 187 with alanine in p27^Kip1 prevents pituitary tumorigenesis by two-hit loss of Rb1 and enhances humoral immunity in old age. J Biol Chem. 290:5797–5809. 2015. View Article : Google Scholar : PubMed/NCBI
4	Ha SY, Lee CH, Chang HK, Chang S, Kwon KY, Lee EH, Roh MS and Seo B: Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27(kip1) and p21(waf1/cip1) in the diagnosis of pulmonary neuroendocrine tumours. Histopathology. 60:731–739. View Article : Google Scholar : PubMed/NCBI
5	Sherr CJ and Roberts JM: CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
6	Dahinden C, Ingold B, Wild P, Boysen G, Luu VD, Montani M, Kristiansen G, Sulser T, Bühlmann P, Moch H and Schraml P: Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clin Cancer Res. 16:88–98. 2010. View Article : Google Scholar : PubMed/NCBI
7	Claret FX, Hibi M, Dhut S, Toda T and Karin M: A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature. 383:453–457. 1996. View Article : Google Scholar : PubMed/NCBI
8	Chamovitz DA and Segal D: JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep. 2:96–101. 2001. View Article : Google Scholar : PubMed/NCBI
9	Schwechheimer C and Deng XW: COP9 signalosome revisited: A novel mediator of protein degradation. Trends Cell Biol. 11:420–426. 2001. View Article : Google Scholar : PubMed/NCBI
10	Sankar U and Means AR: Gfer is a critical regulator of HSC proliferation. Cell Cycle. 10:2263–2268. 2011. View Article : Google Scholar : PubMed/NCBI
11	Porrello E, Rivellini C, Dina G, Triolo D, Del Carro U, Ungaro D, Panattoni M, Feltri ML, Wrabetz L, Pardi R, et al: Jab1 regulates Schwann cell proliferation and axonal sorting through p27. J Exp Med. 211:29–43. 2014. View Article : Google Scholar : PubMed/NCBI
12	Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N and Kato JY: The cytoplasmic shuttling and subsequent degradation of p27^Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem. 277:2302–2310. 2002. View Article : Google Scholar : PubMed/NCBI
13	Li J, Wang Y, Yang C, Wang P, Oelschlager DK, Zheng Y, Tian DA, Grizzle WE, Buchsbaum DJ and Wan M: Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1. Mol Pharmacol. 76:81–90. 2009. View Article : Google Scholar : PubMed/NCBI
14	Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K and Tokuda M: Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Oncol Rep. 15:765–771. 2006.PubMed/NCBI
15	Kitagawa K, Kotake Y and Kitagawa M: Ubiquitin-mediated control of oncogene and tumor suppressor gene products. Cancer Sci. 100:1374–1381. 2009. View Article : Google Scholar : PubMed/NCBI
16	Serres MP, Zlotek-Zlotkiewicz E, Concha C, Gurian-West M, Daburon V, Roberts JM and Besson A: Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro. Oncogene. 30:2846–2858. 2011. View Article : Google Scholar : PubMed/NCBI
17	Kim JH, Go HY, Jin DH, Kim HP, Hong MH, Chung WY, Park JH, Jang JB, Jung H, Shin YC, et al: Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett. 265:197–205. 2008. View Article : Google Scholar : PubMed/NCBI
18	Hung WC, Tseng WL, Shiea J and Chang HC: Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett. 288:156–161. 2010. View Article : Google Scholar : PubMed/NCBI
19	Tosco P, La Terra Maggiore GM, Forni P, Berrone S, Chiusa L and Garzino-Demo P: Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas. Oral Dis. 17:102–108. 2011. View Article : Google Scholar : PubMed/NCBI
20	Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, Monti F, Loda M and Pagano M: Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 110:633–641. 2002. View Article : Google Scholar : PubMed/NCBI
21	Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM and Hershko A: Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer. 91:1745–1751. 2001. View Article : Google Scholar : PubMed/NCBI
22	Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J and Krek W: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA. 98:5043–5048. 2001. View Article : Google Scholar : PubMed/NCBI
23	Di Vizio D, Demichelis F, Simonetti S, Pettinato G, Terracciano L, Tornillo L, Freeman MR and Insabato L: Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. BMC Cancer. 8:1342008. View Article : Google Scholar
24	Rassidakis GZ, Claret FX, Lai R, et al: Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic an aplastic cell lymphoma. Clin Cancer Res. 9:1121–1128. 2003.PubMed/NCBI
25	Xie F, Liu H, Zhu YH, Qin YR, Dai Y, Zeng T, Chen L, Nie C, Tang H, Li Y, et al: Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma. BMC Cancer. 11:862011. View Article : Google Scholar : PubMed/NCBI
26	Ahn J, Hong SA, Lee SE, Kim J, Oh YS, Park SJ and Chung YJ: Cytoplasmic localization of Jab1 and p27^Kip1 might be associated with invasiveness of papillary thyroid carcinoma. Endocr J. 56:707–713. 2009. View Article : Google Scholar : PubMed/NCBI
27	Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, et al: Prognostic significance of S-phase kinase-associated protein 2 and p27^Kip1 in patients with diffuse large B-cell lymphoma: Effects of rituximab. Ann Oncol. 21:833–841. 2010. View Article : Google Scholar : PubMed/NCBI
28	Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massagué J: Cloning of p27^Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:59–66. 1994. View Article : Google Scholar : PubMed/NCBI
29	Carrano AC, Eytan E, Hershko A and Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1:193–199. 1999. View Article : Google Scholar : PubMed/NCBI
30	Qi M, Liu D, Zhang S, Hu P and Sang T: Inhibition of S-phase kinase-associated protein 2-mediated p27 degradation suppresses tumorigenesis and the progression of hepatocellular carcinoma. Mol Med Rep. 11:3934–3940. 2015.PubMed/NCBI
31	Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, et al: Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Ann Surg Oncol. 16:395–403. 2009. View Article : Google Scholar : PubMed/NCBI
32	Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB and Claret FX: Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27^Kip1 in pancreatic adenocarcinoma. Cancer Res. 66:8581–8589. 2006. View Article : Google Scholar : PubMed/NCBI
33	Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C and Dubiel W: COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. Embo J. 20:1630–1639. 2001. View Article : Google Scholar : PubMed/NCBI
34	Naumann M, Bech-Otschir D, Huang X, Ferrell K and Dubiel W: COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem. 274:35297–35300. 1999. View Article : Google Scholar : PubMed/NCBI
35	Pan Y, Zhang Q, Tian L, Wang X, Fan X, Zhang H, Claret FX and Yang H: Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma. Cancer Res. 72:1890–1900. 2012. View Article : Google Scholar : PubMed/NCBI
36	Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E, Moscinski LC, Dalton WS and Tao J: Cell adhesion induces p27^Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas. Blood. 110:1631–1638. 2007. View Article : Google Scholar : PubMed/NCBI
37	Dowen SE, Scott A, Mukherjee G and Stanley MA: Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression. Int J Cancer. 105:326–330. 2003. View Article : Google Scholar : PubMed/NCBI